WinstonWınston
Envoy Medical logo

Envoy Medical

COCHW
16
Medical - Devices · Healthcare
Price
$0.04
+0.00 (+0.00%)
Market Cap
$846,560
Exchange
NASDAQ Capital Market
Winston Score
16
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+93.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 10.2M (2021) → 19.6M (2025)

Envoy Medical is a medical device company that makes hearing implants for people with hearing loss. Its main product is the Acclaim, a fully implanted cochlear device — meaning the entire device goes inside the body with nothing visible on the outside. This makes it different from most hearing aids and cochlear implants, which have external parts that sit behind the ear or on the head.

The company sells its devices to patients through hearing specialists and surgeons, primarily in the United States. Envoy Medical is very small, with a market cap near zero, and its financials show it is spending far more than it earns — a common situation for early-stage medical device companies still seeking broader regulatory clearance and commercial scale. The biggest risk is that the company must generate enough revenue to fund operations before running out of cash, as its deeply negative margins suggest it is not yet self-sustaining.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-15.2% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+71.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$12M/ year

Rising (+23% vs prior year)

>1,000% of revenue

287.8x the sector average (18%)

Investing heavily in future products and technology

Insider Activity

47.9%ownership

Insiders own a meaningful stake in the company

Cash Runway

~12 months

$25M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

Heavy R&D investment

Envoy Medical is putting 5181% of revenue into R&D and that number is rising. That's 287.8x the sector average.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
-702.6%
Thin — -702.6% gross margin
Operating Margin
-15279.5%
Losing money on operations — -15279.5%
ROCE
-56.5%
Weak — -56.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+10.4%
Steady sales growth (10.4% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-8850.4%
Burning cash (-8850.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial